Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of the copper transporter ATP7A
Inaugurates new facilities to further NIMHANS’ mission of delivering cutting-edge care in mental health and neurosciences
DOVBLERON marks the 13th addition to Innovent’s commercial portfolio
MRX-5 is a novel benzoxazole antibiotic developed for the treatment of mycobacteria infections, particularly infections caused by non-tuberculous Mycobacteria
Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
In 2020, CORXEL acquired the rights to develop and commercialize aficamten in Greater China
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
Initiative aimed at enhancing workforce skills and competency in line with industry standards so as to create a talented workforce for the Fourth Industrial Revolution
Subscribe To Our Newsletter & Stay Updated
